Osteoporosis outcomes and treatment patterns in France (20190017)

Study identification

• EU PAS number:
  EUPAS30506
• Study ID:
  45701
• Official title and acronym:
  Osteoporosis outcomes and treatment patterns in France (20190017)
• DARWIN EU® study:
  No
• Study countries:
  France
• Study description:
  This is a retrospective cohort study in the National healthcare data system (Système National des Données de Santée - SNDS) containing French nationwide claims and hospital database including postmenopausal women receiving treatment for osteoporosis. ; The research question is to assess the treatment patterns and the impact of osteoporosis medication on fracture incidence in France. ; The primary objective is to assess the change in fracture risk after treatment initiation among post-menopausal women receiving osteoporosis treatment, overall and stratified by type of treatment and type of fracture
• Study status:
  Finalised

Research institutions and networks

Institutions

Bordeaux PharmacoEpi, University of Bordeaux

France

Bordeaux PharmacoEpi, University of Bordeaux

France

Study timelines

Date when funding contract was signed

Planned:28/06/2019

Actual:28/06/2019

Study start date

Planned:15/06/2020

Actual:08/10/2020

Data analysis start date

Planned:01/08/2020

Actual:23/03/2021

Date of final study report

Planned:31/12/2021

Actual:08/12/2021

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Amgen

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable